Related Experiment Video
Updated: May 30, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Management of pain in multiple sclerosis: a pharmacological approach
Claudio Solaro1, Michele Messmer Uccelli
1Department of Neurology, PA Micone Hospital, ASL3 Genovese, Via Oliva 22, Genoa, 16153, Italy. csolaro@libero.it
Abstract:
About half of patients with multiple sclerosis (MS) report pain; treatment for pain alone accounts for nearly 30% of the total use of medications for the management of all MS-related symptoms. Patients with MS can experience more than one type of pain simultaneously and at any point during the disease course, even in newly or recently diagnosed cases. Pain in MS can be associated with other symptoms, including spasticity, fatigue and mood disorder. Pain sufferers experience disruption in daily life activities, work, mood, recreation and general enjoyment of life, and report low satisfaction with pain management. Many clinical features of pain are often unrecognized by clinicians and are difficult for patients to describe. The majority of clinical evidence regarding treatment stems from small pilot and open-label studies; therefore, treatment of pain associated with MS is often based on anecdotal reports and clinicians' experience. The open-label design of the majority of studies, the unavailability of large samples and the difficulty of performing placebo-controlled studies because of ethical considerations result in insufficient evidence to support or refute the effectiveness of pain medications. This Review presents available data regarding pharmacological approaches for addressing pain in MS and highlights the shortcomings in pain management research.
Insights
Pain is common in multiple sclerosis (MS), affecting about half of patients and impacting daily life. Current pain management strategies for MS lack robust evidence due to study limitations.
Area of Science:
- Neurology
- Pain Medicine
- Pharmacology
Background:
- Pain affects approximately 50% of individuals with multiple sclerosis (MS).
- Pain management in MS accounts for a significant portion (nearly 30%) of all MS-related medication use.
- MS-associated pain can co-occur with other symptoms like spasticity, fatigue, and mood disorders, significantly disrupting patients' quality of life.
Purpose of the Study:
- To review current pharmacological treatments for pain in multiple sclerosis.
- To highlight the limitations and shortcomings in existing research on MS pain management.
Main Methods:
- Review of available clinical evidence on pharmacological approaches for MS pain.
- Analysis of study designs, sample sizes, and ethical considerations in pain management research for MS.
Main Results:
- The majority of evidence for MS pain treatments comes from small, open-label studies.
- Insufficient high-quality evidence exists to definitively support or refute the efficacy of many pain medications for MS.
- Clinical features of MS pain are often underrecognized by clinicians and difficult for patients to articulate.
Conclusions:
- Current pharmacological management of pain in multiple sclerosis is often based on limited evidence and clinical experience.
- There is a critical need for more rigorous, large-scale, and placebo-controlled studies to guide effective MS pain treatment.
- Addressing the complexities of MS pain and improving patient-reported outcomes requires better research methodologies.
Related Concept Videos
Analgesia and Pain Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Multiple Sclerosis l: Introduction
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripheral Artery Disease V: Postoperative Nursing Management

